Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ISWI ATPase Smarca5 Regulates Differentiation of Thymocytes Undergoing β-Selection

T. Zikmund, J. Kokavec, T. Turkova, F. Savvulidi, H. Paszekova, S. Vodenkova, R. Sedlacek, AI. Skoultchi, T. Stopka,

. 2019 ; 202 (12) : 3434-3446. [pub] 20190508

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006387

Grantová podpora
R01 CA079057 NCI NIH HHS - United States
R01 DK096266 NIDDK NIH HHS - United States
NV16-27790A MZ0 CEP - Centrální evidence projektů

Development of lymphoid progenitors requires a coordinated regulation of gene expression, DNA replication, and gene rearrangement. Chromatin-remodeling activities directed by SWI/SNF2 superfamily complexes play important roles in these processes. In this study, we used a conditional knockout mouse model to investigate the role of Smarca5, a member of the ISWI subfamily of such complexes, in early lymphocyte development. Smarca5 deficiency results in a developmental block at the DN3 stage of αβ thymocytes and pro-B stage of early B cells at which the rearrangement of Ag receptor loci occurs. It also disturbs the development of committed (CD73+) γδ thymocytes. The αβ thymocyte block is accompanied by massive apoptotic depletion of β-selected double-negative DN3 cells and premitotic arrest of CD4/CD8 double-positive cells. Although Smarca5-deficient αβ T cell precursors that survived apoptosis were able to undergo a successful TCRβ rearrangement, they exhibited a highly abnormal mRNA profile, including the persistent expression of CD44 and CD25 markers characteristic of immature cells. We also observed that the p53 pathway became activated in these cells and that a deficiency of p53 partially rescued the defect in thymus cellularity (in contrast to early B cells) of Smarca5-deficient mice. However, the activation of p53 was not primarily responsible for the thymocyte developmental defects observed in the Smarca5 mutants. Our results indicate that Smarca5 plays a key role in the development of thymocytes undergoing β-selection, γδ thymocytes, and also B cell progenitors by regulating the transcription of early differentiation programs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006387
003      
CZ-PrNML
005      
20200526083522.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.4049/jimmunol.1801684 $2 doi
035    __
$a (PubMed)31068388
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zikmund, Tomas $u BIOCEV, First Faculty of Medicine, Charles University, Vestec 25250, Czech Republic.
245    10
$a ISWI ATPase Smarca5 Regulates Differentiation of Thymocytes Undergoing β-Selection / $c T. Zikmund, J. Kokavec, T. Turkova, F. Savvulidi, H. Paszekova, S. Vodenkova, R. Sedlacek, AI. Skoultchi, T. Stopka,
520    9_
$a Development of lymphoid progenitors requires a coordinated regulation of gene expression, DNA replication, and gene rearrangement. Chromatin-remodeling activities directed by SWI/SNF2 superfamily complexes play important roles in these processes. In this study, we used a conditional knockout mouse model to investigate the role of Smarca5, a member of the ISWI subfamily of such complexes, in early lymphocyte development. Smarca5 deficiency results in a developmental block at the DN3 stage of αβ thymocytes and pro-B stage of early B cells at which the rearrangement of Ag receptor loci occurs. It also disturbs the development of committed (CD73+) γδ thymocytes. The αβ thymocyte block is accompanied by massive apoptotic depletion of β-selected double-negative DN3 cells and premitotic arrest of CD4/CD8 double-positive cells. Although Smarca5-deficient αβ T cell precursors that survived apoptosis were able to undergo a successful TCRβ rearrangement, they exhibited a highly abnormal mRNA profile, including the persistent expression of CD44 and CD25 markers characteristic of immature cells. We also observed that the p53 pathway became activated in these cells and that a deficiency of p53 partially rescued the defect in thymus cellularity (in contrast to early B cells) of Smarca5-deficient mice. However, the activation of p53 was not primarily responsible for the thymocyte developmental defects observed in the Smarca5 mutants. Our results indicate that Smarca5 plays a key role in the development of thymocytes undergoing β-selection, γδ thymocytes, and also B cell progenitors by regulating the transcription of early differentiation programs.
650    _2
$a adenosintrifosfatasy $x genetika $x metabolismus $7 D000251
650    _2
$a zvířata $7 D000818
650    _2
$a B-lymfocyty $x fyziologie $7 D001402
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a kultivované buňky $7 D002478
650    _2
$a chromozomální proteiny, nehistonové $x genetika $x metabolismus $7 D002868
650    _2
$a klonální selekce zprostředkovaná antigeny $7 D060966
650    _2
$a genová přestavba $7 D015321
650    _2
$a lymfoidní progenitorové buňky $x fyziologie $7 D054503
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a receptory antigenů B-buněk $x genetika $x metabolismus $7 D011947
650    _2
$a receptory antigenů T-buněk alfa-beta $x genetika $x metabolismus $7 D016693
650    _2
$a receptory antigenů T-buněk gama-delta $x genetika $x metabolismus $7 D016692
650    _2
$a T-lymfocyty $x fyziologie $7 D013601
650    _2
$a thymocyty $x fyziologie $7 D060168
650    _2
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kokavec, Juraj $u BIOCEV, First Faculty of Medicine, Charles University, Vestec 25250, Czech Republic.
700    1_
$a Turkova, Tereza $u BIOCEV, First Faculty of Medicine, Charles University, Vestec 25250, Czech Republic.
700    1_
$a Savvulidi, Filipp $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic.
700    1_
$a Paszekova, Helena $u BIOCEV, First Faculty of Medicine, Charles University, Vestec 25250, Czech Republic.
700    1_
$a Vodenkova, Sona $u Institute of Experimental Medicine, Czech Academy of Sciences, Prague 14220, Czech Republic. Third Faculty of Medicine, Charles University, Prague 10000, Czech Republic.
700    1_
$a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, Vestec 25250, Czech Republic; and.
700    1_
$a Skoultchi, Arthur I $u Department of Cell Biology, Albert Einstein College of Medicine, Bronx 10461, NY.
700    1_
$a Stopka, Tomas $u BIOCEV, First Faculty of Medicine, Charles University, Vestec 25250, Czech Republic; tstopka@lf1.cuni.cz.
773    0_
$w MED00002741 $t Journal of immunology (Baltimore, Md. : 1950) $x 1550-6606 $g Roč. 202, č. 12 (2019), s. 3434-3446
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31068388 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526083518 $b ABA008
999    __
$a ok $b bmc $g 1525245 $s 1096443
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 202 $c 12 $d 3434-3446 $e 20190508 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741
GRA    __
$a R01 CA079057 $p NCI NIH HHS $2 United States
GRA    __
$a R01 DK096266 $p NIDDK NIH HHS $2 United States
GRA    __
$a NV16-27790A $p MZ0
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace